Minnesota Epilepsy Group, P.A.

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Epilepsy3 trials

Phase

• Phase 21 trial
• Phase 2/31 trial
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Enrolling by invitation1 trial
• Recruiting1 trial

Lead sponsor

• Biohaven Therapeutics Ltd.2 trials
• Epygenix1 trial

Running trials

• Recruiting

  An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome

  NCT05066217· Phase 3· Epygenix· Source

  Contact: Sarah Ellis, MD

• Enrolling by invitation

  Long-term Safety and Tolerability of BHV-7000

  NCT06443463· Phase 2· Biohaven Therapeutics Ltd.· Source

• Active, not recruiting

  A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

  NCT06132893· Phase 2/3· Biohaven Therapeutics Ltd.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Epilepsy2 recruiting